JF Pagel has authored more than 170 publications. His basic research addressed the electrophysiology of consciousness, the neurochemistry of sleep and dream, and the role of REM sleep in learning and memory. His clinical work includes proofs for non-dreaming and the requirement of sleep for dream and nightmare, the diagnostic code for nightmare disorder, a definition protocol for dream, and demonstrations that REM sleep and dreaming are doubly dissociable. He has developed approaches to treating insomnia, sleep & altitude, narcolepsy, pediatric parasomnias, and waking somnolence, as well as addressing dream and nightmare use in trauma, art, creativity and filmmaking. He is co-editor of one of the major sleep-medicine texts: Primary Care Sleep Disorders (2007/ 2014). His books include: The Limits of Dream - A Scientific Exploration of the Mind /Brain Interface (2007), Dreaming and Nightmares (ed.) (2010), and Dream Science - Exploring the Forms of Consciousness (2014).
The chapters include more than 100 boxes describing clinical conditions, techniques, and other special topics. Each chapter went through a thorough review process, giving the book an evenness of tone. The chapters are authored by outstanding working scientists who are experts on the topics they cover.Selected for inclusion in Doody's Core Titles 2013, an essential collection development tool for health sciences libraries30% new material including new chapters on dendritic development and spine morphogenesis, chemical senses, cerebellum, eye movements, circadian timing, sleep and dreaming, and consciousnessAccompanying website for students and instructorsAdditional text boxes describing key experiments, disorders, methods, and conceptsMore than 650 four-color illustrations, micrographs, and neuroimages Multiple model system coverage beyond rats, mice, and monkeysExtensively expanded index for easier referencing
This volume presents neuroprotection and novel therapeutic strategies developed in the last 5 years by 12 world leaders in the field. The term neuroprotection means rescuing neuronal and non-neuronal cells together. The cerebral endothelium that constitutes the anatomical and physiological site of the blood-brain barrier (BBB) is one of the most important non-neural cells in the CNS. Any distortion of the BBB leads to brain diseases and restoration of the barrier results in neuroprotection. Thus, the BBB appears to be the "gateway" for neurological diseases and neurorepair. However, to treat brain tumors or infarcts, new therapeutic strategies are needed to enhance brain drug delivery using nanotechnology. In addition, apart from conventional drugs, restoration of BBB function could also be achieved by means of antibodies directed against specific proteins, neurotransmitters or exogenous supplement of neurotrophic factors. Since co-morbidity factors e.g., hypertension, diabetes, and exposure of nanoparticles could complicate the pathogenesis of neurological disorders either an enhanced dose of the drug or nanodelivery of a combination of several drugs is needed to achieve neuroprotection.
This volume of International Review of Neurobiology is the first to discuss novel therapeutic strategies in situations of neurological disorders in combination with different co-morbidity factors.Reviews written by experts in such a way that provides basic knowledge for beginners and advanced information for researchers and expertsNew aspects of Neurodegenerative diseases such as; Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis are presented with the latest therapeutic measuresExacerbation of brain pathology in hypertension or diabetes is discussed for the first time
Collectively, neurodegenerative diseases are characterized by chronic and progressive loss of neurons in discrete areas of the brain, producing debilitating symptoms such as dementia, loss of memory, loss of sensory or motor capability, decreased overall quality of life eventually leading to premature death. Two types of cell death are known to occur during neurodegeneration: (a) apoptosis and (b) necrosis. The necrosis is characterized by the passive cell swelling, intense mitochondrial damage with rapid loss of ATP, alterations in neural membrane permeability, high calcium influx, and disruption of ion homeostasis. This type of cell death leads to membrane lysis and release of intracellular components that induce inflammatory reactions. Necrotic cell death normally occurs at the core of injury site. In contrast, apoptosis is an active process in which caspases (a group of endoproteases with specificity for aspartate residues in protein) are stimulated. Apoptotic cell death is accompanied by cell shrinkage, dynamic membrane blebbing, chromatin condensation, DNA laddering, loss of phospholipids asymmetry, low ATP levels, and mild calcium overload. This type of cell death normally occurs in penumbral region at the ischemic injury site and in different regions in various neurodegenerative diseases.
Thus, apoptosis and necrosis are two extremes of a wide spectrum of cell death processes with different mechanistic and morphological features. However, they may share some common mediators and signal transduction processes that are often inseparable. Although the molecular mechanism of neurodegeneration remains unknown, it is becoming increasingly evident that excitotoxicity, inflammation, and oxidative stress may contribute to neural cell demise independently or synergistically. During aging an upregulation of interplay (cross talk) among exicitotoxicity, oxidative stress, and neuroinflammation occurs throughout the normal elderly brain, but in neurodegenerative diseases this interplay turns on specific genes that affect only a specific neuronal population in a particular region where neuronal degeneration occurs both by apoptotic and necrotic cell death.
Today, such evidence-based breakthroughs in the field of dream science are altering our understanding of consciousness. Different forms of dreaming consciousness occur throughout sleep, and dreamlike states extend into wake. Each dream state is developed on a framework of memories, emotions, representational images, and electrophysiology, amenable to studies utilizing emerging and evolving technology. Dream Science discusses basic insights into the scientific study of dreaming, including the limits to traditional Freudian-based dream theory and the more modern evidence-based science. It also includes coverage of the processes of memory and parasomnias, the sleep-disturbance diagnoses related to dreaming. This comprehensive book is a scientific exploration of the mind-brain interface and a look into the future of dream science.Provides a more evidence-based approach than any other work on the marketSingle source of integrated information on all aspects of dream science makes this a critical time-saving reference for researchers and cliniciansAuthored by one of the leaders in the field of dream research